HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shao, J. Articles by Friedman, J. E. Search for Related Content PubMed PubMed Citation Articles by Shao, J. Articles by Friedman, J. E. Social Bookmarking                What's this?

Chronic Hyperglycemia Enhances PEPCK Gene Expression and Hepatocellular Glucose Production Via Elevated Liver Activating Protein/Liver Inhibitory Protein Ratio

¹ Department of Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado
² Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, Colorado
³ Department of Biochemistry and Molecular Genetics, University of Colorado Health Sciences Center, Denver, Colorado

Acute hyperglycemia normally suppresses hepatic glucose production (HGP) and gluconeogenic gene expression. Conversely, chronic hyperglycemia is accompanied by progressive increases in basal HGP and is a major contributor to hyperglycemia in both type 1 and type 2 diabetes by mechanisms that are poorly understood. The aim of this study was to investigate the molecular mechanisms whereby hyperglycemia contributes to excessive gluconeogenesis in Fao hepatoma cells. Increasing glucose from 5 to 20 mmol/l resulted in loss of glucose inhibition of PEPCK gene expression after 12 h. Furthermore, 24 h of incubation with 20 mmol/l glucose increased cAMP-stimulated PEPCK mRNA by 40% (P < 0.05) and similarly increased glucose production. Although total CCAAT/enhancer-binding protein ß (C/EBPß) protein levels were suppressed, 20 mmol/l glucose increased the liver activating protein (LAP; an active isoform of C/EBPß)/liver inhibitory protein (LIP; an inhibitory isoform of C/EBPß) ratio significantly. Chromatin immunoprecipitation studies of the endogenous PEPCK gene demonstrated an increased association of LAP with the cAMP response element of the promoter. Using transient transfection to manipulate the LAP/LIP ratio, we also demonstrate a direct relationship between this ratio and PEPCK promoter activity. An increased LAP/LIP ratio not only enhanced cAMP- and dexamethasone-induced PEPCK gene expression but also impaired the repressive effect of insulin. These results demonstrate that sustained hyperglycemia diminishes the inhibitory effect of glucose and insulin on PEPCK expression and enhances hormone-stimulated PEPCK gene expression and hepatocellular glucose production. Because prolonged hyperglycemia increases the LAP/LIP ratio and can potentiate hormone induction of PEPCK transcription, our results suggest that a hyperglycemia-driven increased LAP/LIP ratio may be a critical molecular event in the pathogenesis of increased HGP in diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Yan, Z. Gao, G. Yu, Q. He, J. Weng, and J. Ye Nuclear Corepressor Is Required for Inhibition of Phosphoenolpyruvate Carboxykinase Expression by Tumor Necrosis Factor-{alpha} Mol. Endocrinol., July 1, 2007; 21(7): 1630 - 1641. [Abstract] [Full Text] [PDF]

				M. Dodig, B. Ogunwale, S. Dasarathy, M. Li, B. Wang, and A. J. McCullough Differences in regulation of type I collagen synthesis in primary and passaged hepatic stellate cell cultures: the role of {alpha}5beta1-integrin Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G154 - G164. [Abstract] [Full Text] [PDF]

				J. M. Schroeder-Gloeckler, S. M. Rahman, R. C. Janssen, L. Qiao, J. Shao, M. Roper, S. J. Fischer, E. Lowe, D. J. Orlicky, J. L. McManaman, et al. CCAAT/Enhancer-binding Protein beta Deletion Reduces Adiposity, Hepatic Steatosis, and Diabetes in Leprdb/db Mice J. Biol. Chem., May 25, 2007; 282(21): 15717 - 15729. [Abstract] [Full Text] [PDF]

				L. T. Timchenko, E. Salisbury, G.-L. Wang, H. Nguyen, J. H. Albrecht, J. W. B. Hershey, and N. A. Timchenko Age-specific CUGBP1-eIF2 Complex Increases Translation of CCAAT/Enhancer-binding Protein beta in Old Liver J. Biol. Chem., October 27, 2006; 281(43): 32806 - 32819. [Abstract] [Full Text] [PDF]

				L. Qiao, O. A. MacDougald, and J. Shao CCAAT/Enhancer-binding Protein {alpha} Mediates Induction of Hepatic Phosphoenolpyruvate Carboxykinase by p38 Mitogen-activated Protein Kinase J. Biol. Chem., August 25, 2006; 281(34): 24390 - 24397. [Abstract] [Full Text] [PDF]

				L. Qiao, P. S. MacLean, H. You, J. Schaack, and J. Shao Knocking Down Liver CCAAT/Enhancer-Binding Protein {alpha} by Adenovirus-Transduced Silent Interfering Ribonucleic Acid Improves Hepatic Gluconeogenesis and Lipid Homeostasis in db/db Mice Endocrinology, June 1, 2006; 147(6): 3060 - 3069. [Abstract] [Full Text] [PDF]

				L. Qiao, J. Schaack, and J. Shao Suppression of Adiponectin Gene Expression by Histone Deacetylase Inhibitor Valproic Acid Endocrinology, February 1, 2006; 147(2): 865 - 874. [Abstract] [Full Text] [PDF]

				C. A Maloney and W. D Rees Gene-nutrient interactions during fetal development Reproduction, October 1, 2005; 130(4): 401 - 410. [Abstract] [Full Text] [PDF]